PubMed · 13207079
The source did not provide an abstract. Follow the original record for more information.
Explore connections, maps & timelines
M B LEVIN. 1954. Benzidine test for blood (Levin-Watt).. https://doi.org/10.1007/bf02883991
Cite the original work for its findings. Save a collection to share your selection of sources.
KEEP EXPLORING
Explore the source record for details and available documents.
There is a need for improved methods for detecting individuals at risk for cancer to target subsets of patients for more intensive individual screening and targeted cancer therapy and chemoprevention. One approach for accomplishing this objective is to detect premalignant molecular fingerprints in an organ at risk for cancer or to define biomarkers reflective of treatment selection and response. Bladder cancer is an excellent model for testing this approach; however, comprehending the strategy for biomarker selection and analysis is more complicated than is generally appreciated. The objective of this article is to provide a succinct overview of our experience with the selection of biomarkers for bladder cancer detection, first in symptomatic patients and then in high-risk cohorts of workers at risk for bladder cancer. Biomarker selection depends on multiple parameters, each of which must be optimized to enhance the utility of a biomarker for clinical application. Many markers that initially show promise fail in the clinical arena for a variety of reasons. Important parameters include when a biomarker is expressed in carcinogenesis (i.e., early vs. late), the sample type, and the method of analysis. These all contribute to the sensitivity, specificity, and ultimate clinical utility of a biomarker. New technologies/ support the notion that all diseases start in the cell, and Seymore West indicated the cell, under appropriate conditions, can function as a microcuvette for biophysical cytochemical analysis. Spectroscopy provides an accurate and sensitive method for quantitative single-cell proteomics. Improved and more stable fluorescence probes will enhance the utility of cellular chemistry, as will a rationale approach for biomarker selection based on the concepts of field cancerization, complemented by improved quantitative analysis of protein markers at the single-cell level. Our laboratory has developed a platform for single-cell proteomic analysis that can be applied to multiple basic science and clinical problems. Single-cell proteomics also facilitates the study of genetic instability and epigenetic signaling (stromal-epithelial interactions) in relation to cancer therapy and diagnosis. Because most cancers arise through multiple signaling pathways and are heterogeneous, the identification of appropriate biomarker profiles provides a number of strategic advantages over a single biomarker. Complex networks of signaling pathways lead to increased cell proliferation, decreased cell adhesion, cellular differentiation, genetic instability, and other functions associated with the malignant phenotype. The purpose of this presentation is to illustrate the fundamental concepts for selection and profile analysis of high-level phenotypic biomarkers developed for bladder cancer risk assessment, screening, and early bladder cancer detection.
We focused our studies on the fabrication of nano-organized systems incorporating redox mediators for NADH. We fabricated gold-modified electrodes of phospholipid layers containing a redox mediator for NADH by means of the Langmuir-Blodgett (LB) technique. We chose tetramethylbenzidine (TMB) which is known to decrease the very large overvoltage involved in the direct oxidation of NADH. The electrochemical characterisation of the films allowed to determine the presence and the electrochemical activity of the mediator in the LB layers. The response of the sensing layer in solutions containing NADH was investigated by means of cyclic voltammetry and fluorescence spectroscopy. We observed that NADH has a strong affinity with the film, and it interacts with the TMB-containing phospholipid layers. In fact, we found that TMB molecules mediate the NADH oxidation reaction, even if the surrounding matrix relatively hinders their mobility.